Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radioprotective effect of metformin against radiotherapy-induced complications in prostate cancer
IRCT20211213053377N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metformin in prostate cancer (PCa), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Jan 2022; status: completed.
02
Drugs
metformin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on IRCT20211213053377N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211213053377N1.